advertisement
Shiga Y 33
Showing records 1 to 25 | Display all abstracts from Shiga Y84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Kim YW
Scientific reports 2020; 10: 221
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Yabana T
PLoS ONE 2019; 14: e0227078
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Uchida K
Scientific reports 2020; 10: 545
84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Kim YJ
Scientific reports 2020; 10: 221
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Sato K
PLoS ONE 2019; 14: e0227078
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Himori N
Scientific reports 2020; 10: 545
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Hashimoto K
Scientific reports 2020; 10: 545
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288
84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Cheong HS
Scientific reports 2020; 10: 221
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Shiga Y
PLoS ONE 2019; 14: e0227078
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T
Scientific reports 2019; 9: 19288
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Shiga Y
Scientific reports 2020; 10: 545
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Himori N
PLoS ONE 2019; 14: e0227078
84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Shiga Y
Scientific reports 2020; 10: 221
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Tsuda S
Scientific reports 2020; 10: 545
84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Hashimoto K
Scientific reports 2020; 10: 221
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shimazaki A
Scientific reports 2019; 9: 19288
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Omodaka K
PLoS ONE 2019; 14: e0227078
84975 The association between oxidative stress and corneal hysteresis in patients with glaucoma
Omodaka K
Scientific reports 2020; 10: 545
84839 The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma
Nakazawa T
PLoS ONE 2019; 14: e0227078
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakamura M
Scientific reports 2019; 9: 19288
84941 Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study
Song YJ
Scientific reports 2020; 10: 221
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shiga Y
Scientific reports 2019; 9: 19288
